News
Orion Office REIT Inc. (NYSE:ONL) Q2 2023 Results Conference Call August 10, 2023 10:00 AM ET Company Participants Paul Hughes – General Counsel Paul...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Masahiko MoriyamaPresident & Representative Director This is Moriyama from T&D Holdings. Thank you very much for taking the time out of your busy schedules...
News
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
News
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
News
Housing costs continue to drive up U.S. consumer prices up in July, but economists are expecting a slowdown in the coming months. The rise...
News
In this article I cover the O’Shaughnessy Tiny Titans stock-picking strategy and give you a list of stocks currently passing our screen based on...
News
Technical Analysis If we pull up a short-term chart of Perma-Fix Environmental Services, Inc. (NASDAQ:PESI), we see that we have a potential ascending triangle...
News
Cyberthieves love convenience and reaching victims directly. That’s why they increasingly use texting through an activity called “smishing.” Some $330 million was stolen through...
News
July Headline CPI came in at +0.2%, in line with expectations, while the Core CPI rate also printed +0.2%. On a year-on-year basis, the...
News
I’m 49, I live in a major metropolitan area and I have a $540,000 mortgage. I earn six figures ($185,000 a year, excluding bonuses)....
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
This article is reprinted by permission from NerdWallet. The morning after the hurricane hit Florida, I got a text from my tenant. “I have...
News
Introduction Tango Therapeutics (NASDAQ:TNGX) focuses on the discovery and development of next-generation precision medicines to target cancer, specifically aiming at tumor suppressor gene loss....
